NCT07218146 Phase 3 Recruiting
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE) Study sponsor: Zai Lab (Shanghai) Co., Ltd.
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Changes Study details Primary completion 2028-06-30 Estimated
Enrollment · participants 480 Estimated
Source updated 2026-09-14 Last update listed in the registry record
Version history
Changes to this trial Last 12 months
Posted 2026-01-15 · 3 fields changed
Planned enrollment decreased by 185 participants
− Before 665 participants (planned)
+ After 480 participants (planned)
Primary completion date changed
Recruitment status changed
− Before Not yet recruiting
Check registry source
This database covers selected trials and recorded edits. Some past edits may be missing, and saved text about the main study measures (endpoints) may be shortened. Check the original registry record when a detail matters. Read our methodology
Trial